| D68.0 |
Von Willebrand disease [+]
| Excludes 1: |
capillary fragility (hereditary) (D69.8)
factor VIII deficiency NOS (D66)
factor VIII deficiency with functional defect (D66)
|
|
|
| D68.00 |
Von Willebrand disease, unspecified
|
| D68.01 |
Von Willebrand disease, type 1
Partial quantitative deficiency of von Willebrand factor
Type 1C von Willebrand disease
|
| D68.02 |
Von Willebrand disease, type 2 [+]
Qualitative defects of von Willebrand factor
|
|
| D68.020 |
Von Willebrand disease, type 2A
Qualitative defects of von Willebrand factor with decreased platelet adhesion and selective deficiency of high-molecular-weight multimers
|
| D68.021 |
Von Willebrand disease, type 2B
Qualitative defects of von Willebrand factor with high-molecular-weight von Willebrand factor loss
Qualitative defects of von Willebrand factor with hyper-adhesive forms
Qualitative defects of von Willebrand factor with increased affinity for platelet glycoprotein lb
|
| D68.022 |
Von Willebrand disease, type 2M
Qualitative defects of von Willebrand factor with defective platelet adhesion with a normal size distribution of von Willebrand factor multimers
|
| D68.023 |
Von Willebrand disease, type 2N
Qualitative defects of von Willebrand factor with defective von Willebrand factor to factor VIII binding
Qualitative defects of von Willebrand factor with markedly decreased affinity for factor VIII
|
| D68.029 |
Von Willebrand disease, type 2, unspecified
Qualitative defect in von Willebrand factor function, with no further subtyping
|
|
| D68.03 |
Von Willebrand disease, type 3
(Near) complete absence of von Willebrand factor
Total quantitative deficiency of von Willebrand factor
|
| D68.04 |
Acquired von Willebrand disease
Acquired von Willebrand syndrome
|
| D68.09 |
Other von Willebrand disease
Platelet-type von Willebrand disease
Pseudo-von Willebrand disease
| Code also |
, if applicable, qualitative platelet defects (D69.1)
|
|
|
| D68.1 |
Hereditary factor XI deficiency
Hemophilia C
Plasma thromboplastin antecedent [PTA] deficiency
Rosenthal's disease
|
| D68.2 |
Hereditary deficiency of other clotting factors
AC globulin deficiency
Congenital afibrinogenemia
Deficiency of factor I [fibrinogen]
Deficiency of factor II [prothrombin]
Deficiency of factor V [labile]
Deficiency of factor VII [stable]
Deficiency of factor X [Stuart-Prower]
Deficiency of factor XII [Hageman]
Deficiency of factor XIII [fibrin stabilizing]
Dysfibrinogenemia (congenital)
Hypoproconvertinemia
Owren's disease
Proaccelerin deficiency
|
| D68.3 |
Hemorrhagic disorder due to circulating anticoagulants [+]
|
|
| D68.31 |
Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors [+]
|
|
| D68.311 |
Acquired hemophilia
Autoimmune hemophilia
Autoimmune inhibitors to clotting factors
Secondary hemophilia
|
| D68.312 |
Antiphospholipid antibody with hemorrhagic disorder
Lupus anticoagulant (LAC) with hemorrhagic disorder
Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
| Excludes 1: |
antiphospholipid antibody, finding without diagnosis (R76.0)
antiphospholipid antibody syndrome (D68.61)
antiphospholipid antibody with hypercoagulable state (D68.61)
lupus anticoagulant (LAC) finding without diagnosis (R76.0)
lupus anticoagulant (LAC) with hypercoagulable state (D68.62)
systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.62)
|
|
| D68.318 |
Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
Antithromboplastinemia
Antithromboplastinogenemia
Hemorrhagic disorder due to intrinsic increase in antithrombin
Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
Hemorrhagic disorder due to intrinsic increase in anti-IXa
Hemorrhagic disorder due to intrinsic increase in anti-XIa
|
|
| D68.32 |
Hemorrhagic disorder due to extrinsic circulating anticoagulants
Drug-induced hemorrhagic disorder
Hemorrhagic disorder due to increase in anti-IIa
Hemorrhagic disorder due to increase in anti-Xa
Hyperheparinemia
| Use additional |
code for adverse effect, if applicable, to identify drug (T45.515, T45.525) |
|
|
| D68.4 |
Acquired coagulation factor deficiency
Deficiency of coagulation factor due to liver disease
Deficiency of coagulation factor due to vitamin K deficiency
| Excludes 1: |
vitamin K deficiency of newborn (P53)
|
|
| D68.5 |
Primary thrombophilia [+]
Primary hypercoagulable states
| Excludes 1: |
antiphospholipid syndrome (D68.61)
lupus anticoagulant (D68.62)
secondary activated protein C resistance (D68.69)
secondary antiphospholipid antibody syndrome (D68.69)
secondary lupus anticoagulant with hypercoagulable state (D68.69)
secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)
systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)
thrombotic thrombocytopenic purpura (M31.19)
|
|
|
| D68.51 |
Activated protein C resistance
Factor V Leiden mutation
|
| D68.52 |
Prothrombin gene mutation
|
| D68.59 |
Other primary thrombophilia
Antithrombin III deficiency
Hypercoagulable state NOS
Primary hypercoagulable state NEC
Primary thrombophilia NEC
Protein C deficiency
Protein S deficiency
Thrombophilia NOS
|
|
| D68.6 |
Other thrombophilia [+]
Other hypercoagulable states
| Excludes 1: |
diffuse or disseminated intravascular coagulation [DIC] (D65)
heparin induced thrombocytopenia (HIT) (D75.82-)
hyperhomocysteinemia (E72.11)
|
|
|
| D68.61 |
Antiphospholipid syndrome
Anticardiolipin syndrome
Antiphospholipid antibody syndrome
| Excludes 1: |
anti-phospholipid antibody, finding without diagnosis (R76.0)
anti-phospholipid antibody with hemorrhagic disorder (D68.312)
lupus anticoagulant syndrome (D68.62)
|
|
| D68.62 |
Lupus anticoagulant syndrome
Lupus anticoagulant
Presence of systemic lupus erythematosus [SLE] inhibitor
| Excludes 1: |
anticardiolipin syndrome (D68.61)
antiphospholipid syndrome (D68.61)
lupus anticoagulant (LAC) finding without diagnosis (R76.0)
lupus anticoagulant (LAC) with hemorrhagic disorder (D68.312)
|
|
| D68.69 |
Other thrombophilia
COVID-19 associated hypercoagulability
Hypercoagulable states NEC
Secondary hypercoagulable state NOS
| Code also |
, if applicable, associated condition
|
|
|
| D68.8 |
Other specified coagulation defects
COVID-19 associated coagulopathy
| Code also |
, if applicable, associated condition
|
| Excludes 1: |
hemorrhagic disease of newborn (P53)
|
|
| D68.9 |
Coagulation defect, unspecified
|